Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer.

Eck SM, Blackburn JS, Schmucker AC, Burrage PS, Brinckerhoff CE.

J Autoimmun. 2009 Nov-Dec;33(3-4):214-21. doi: 10.1016/j.jaut.2009.09.011. Epub 2009 Oct 1. Review.

2.

Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.

Chow BS, Chew EG, Zhao C, Bathgate RA, Hewitson TD, Samuel CS.

PLoS One. 2012;7(8):e42714. doi: 10.1371/journal.pone.0042714. Epub 2012 Aug 22.

3.

Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.

Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J.

J Biol Chem. 2000 Jan 7;275(1):444-50.

4.

Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis.

Ho IA, Yulyana Y, Sia KC, Newman JP, Guo CM, Hui KM, Lam PY.

FASEB J. 2014 Oct;28(10):4359-68. doi: 10.1096/fj.14-252551. Epub 2014 Jun 30.

PMID:
25271298
5.
6.

CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients.

García-Vicuña R, Gómez-Gaviro MV, Domínguez-Luis MJ, Pec MK, González-Alvaro I, Alvaro-Gracia JM, Díaz-González F.

Arthritis Rheum. 2004 Dec;50(12):3866-77.

7.
8.

A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Blackburn JS, Liu I, Coon CI, Brinckerhoff CE.

Oncogene. 2009 Dec 3;28(48):4237-48. doi: 10.1038/onc.2009.272. Epub 2009 Sep 7.

9.

CXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells.

Eck SM, Côté AL, Winkelman WD, Brinckerhoff CE.

Mol Cancer Res. 2009 Jul;7(7):1033-44. doi: 10.1158/1541-7786.MCR-09-0015. Epub 2009 Jul 7.

11.

Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.

Docampo MJ, Cabrera J, Rabanal RM, Bassols A.

Am J Vet Res. 2011 Aug;72(8):1087-96. doi: 10.2460/ajvr.72.8.1087.

PMID:
21801067
14.

Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.

Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC.

Arch Dermatol Res. 2005 Oct;297(4):154-60. Epub 2005 Oct 26.

PMID:
16047212
15.

The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.

Abreu JR, de Launay D, Sanders ME, Grabiec AM, van de Sande MG, Tak PP, Reedquist KA.

Arthritis Res Ther. 2009;11(4):R121. doi: 10.1186/ar2785. Epub 2009 Aug 13.

17.

TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.

Yin M, Soikkeli J, Jahkola T, Virolainen S, Saksela O, Hölttä E.

Am J Pathol. 2012 Dec;181(6):2202-16. doi: 10.1016/j.ajpath.2012.08.027. Epub 2012 Oct 10.

PMID:
23063511
18.

Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.

Pakozdi A, Amin MA, Haas CS, Martinez RJ, Haines GK 3rd, Santos LL, Morand EF, David JR, Koch AE.

Arthritis Res Ther. 2006;8(4):R132.

19.

The SCID mouse model: novel therapeutic targets - lessons from gene transfer.

Pierer M, Müller-Ladner U, Pap T, Neidhart M, Gay RE, Gay S.

Springer Semin Immunopathol. 2003 Aug;25(1):65-78. Review.

PMID:
12904892
20.

In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.

Tondreau T, Meuleman N, Stamatopoulos B, De Bruyn C, Delforge A, Dejeneffe M, Martiat P, Bron D, Lagneaux L.

Cytotherapy. 2009;11(5):559-69. doi: 10.1080/14653240903051541.

PMID:
19551542

Supplemental Content

Support Center